RAD52 and chronic myelogenous leukemia, BCR-ABL1 positive: Consequently, hindering the binding capability of RAD52 prohibited the proliferative and clonogenic potential of CML-CP leukemia stem and progenitor cells due to the cells’ oncogenic addiction to Rad52 DNA repair.